On Tuesday, Shares of Noble Energy, Inc. (NYSE:NBL), lost 0.41% to $29.70.
Noble Energy, declared that the Cheetah exploration well in the Tilapia license offshore Cameroon reached the targeted Cretaceous interval and is being plugged and abandoned. The well encountered both crude oil and natural gas shows in multiple non-commercial reservoir sands. Results from the well are being integrated into the Company’s geologic modeling for the remaining prospectivity in the Tilapia license. The rig, which drilled the Cheetah well to a total depth of about 13,320 feet, will be released at the completion of well operations.
Noble Energy operated the Cheetah well with a 47 percent participating interest.
Noble Energy (NBL) is a global independent oil and natural gas exploration and production company with total proved reserves of 1.7 billion barrels of oil equivalent at year-end 2014 (pro forma for the Rosetta acquisition). The company’s diverse resource base comprises positions in four premier unconventional U.S. onshore plays - the DJ Basin, Eagle Ford Shale, Delaware Basin, and Marcellus Shale - and offshore in the U.S. Gulf of Mexico, Eastern Mediterranean and West Africa. Driven by its purpose, Energizing the World, Bettering People’s Lives(R), the company is committed to safely and responsibly providing energy to the world while positively impacting the lives of our stakeholders.
Noble Energy, Inc., an independent energy company, engages in the acquisition, exploration, and production of crude oil, natural gas, and natural gas liquids worldwide. Its principal projects are located in onshore DJ Basin and Marcellus Shale, the United States; the deepwater Gulf of Mexico; offshore West Africa; and offshore Eastern Mediterranean.
Shares of Advaxis, Inc. (NASDAQ:ADXS), declined -16.65% to $10.16, during its last trading session.
ACI Association has initiated research coverage on the following equities: Celldex Therapeutics, Inc. (CLDX), Alexion Pharmaceuticals, Inc. (ALXN), Advaxis, Inc. (ADXS), BioDelivery Sciences International, Inc. (BDSI), Cytori Therapeutics Inc. (CYTX). On Monday, September 28, 2015, NASDAQ ended at 4,543.97 down 3.04%, Dow Jones declined 1.92%, to finish the day at 16,001.89, and the S&P closed at 1,881.77, down 2.57%. Register for your complimentary reports at the links given below.
Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States.
At the end of Tuesday’s trade, Shares of Heron Therapeutics Inc (NASDAQ:HRTX), lost -8.61% to $21.34.
Heron Therapeutics, declared that data from the accomplished Phase 3 MAGIC study of SUSTOL (granisetron) Injection, extended release, were presented by Ian Schnadig, M.D., Principal Investigator for the MAGIC trial, US Oncology Research, Compass Oncology, at the American Society of Clinical Oncology (ASCO) 2015 Breast Cancer Symposium in San Francisco, CA. These data were presented in an oral presentation and poster titled “Phase III Study of APF530 as compared to Ondansetron with a Neurokinin 1 Antagonist + Corticosteroid in Preventing Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: MAGIC Trial.” SUSTOL is Heron’s lead product candidate for the prevention of chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC). SUSTOL has not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Heron Therapeutics represented its New Drug Application (NDA) for SUSTOL with the FDA in July 2015.
Heron Therapeutics, Inc. is a biotechnology company. The Company uses its technology to develop products to address unmet medical needs. Its Biochronomer polymer-based drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals.
Finally, Marriott International Inc (NASDAQ:MAR), ended its last trade with -1.10% loss, and closed at $65.44.
Starting this season, couples hosting their destination wedding at The Ritz-Carlton, St. Thomas will now have the opportunity to give back to the Caribbean island community as part of their experience. “Lasting Contributions” was created to assist couples build the idea of service and community work into their special day, inspiring lasting memories with their loved ones. The program is inspired by The Ritz-Carlton Community Footprints program, a renowned corporate social responsibility program embedded into The Ritz-Carlton service values.
Before the big day, the couple and their wedding party will have the chance to choose from a number of service opportunities offered by the resort, counting a visit the Boys & Girls Club of the U.S. Virgin Islands to spend time with local children, assisting them with their school work and working together on creative art projects. Child wellbeing is one of three key pillars of the Community Footprints program, with hotels around the world partnering with local organizations that provide a safe haven and nurturing environment for children. For couples seeking other kinds of experiences, The Ritz-Carlton, St. Thomas will provide a list of other partner opportunities around the island.
“Increasingly, we find that all kinds of travelers, counting those traveling for their wedding, are looking for a more authentic, local experience as a way to fully immerse themselves into the destination,” said Cliff Brutus, director of sales and marketing for the resort. “We created this exciting new program for our guests who are looking for meaningful experiences that also benefit the local community.”
Marriott International, Inc. operates, franchises, and licenses hotels and timeshare properties worldwide. It operates through three segments: North American Full-Service, North American Limited-Service, and International.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
